A new study reveals that “seek & destroy” therapy can potentially help in treating prostate cancer. As per the team of researchers at the Beatson Institute and the University of Strathclyde in the United Kingdom, the given therapeutic system is capable of halting a significant portion of prostate tumors in the lab models. The particular [...]

A new study reveals that “seek & destroy” therapy can potentially help in treating prostate cancer. As per the team of researchers at the Beatson Institute and the University of Strathclyde in the United Kingdom, the given therapeutic system is capable of halting a significant portion of prostate tumors in the lab models.

The particular therapeutic system has been utilized against treating two major types of prostate cancer, leading to the vanishing of around 70 percent of one type of cancer and around 50 percent of the other cancer type over the period of one month. The results of the given study have been published in the journal named Drug Delivery. The results appear promising as a revolutionary system that can serve as a boon in the treatment of prostate cancer.

[AdSense-B]

Prostate cancer stands 4th in the most widespread form of cancer in the world. Moreover, it is also the 2nd most common type of cancer in men. Researchers claim that prostate cancer is most commonly found in cases of men from America and Europe. Causing over 300,000 deaths of the patients per year across the world, prostate cancer has only increased continually in the past few decades.

Christine Dufes –University of Strathclyde’s Senior Lecturer, says, “Although major treatments like radiotherapy and chemotherapy can be effective in treating localized tumors, there is still the absence of an effective treatment in cases wherein cancer spreads or recurs.”

This implies that promising therapeutic systems are urgently needed for ensured treatments. For addressing the situation, the team of researchers has come up with the revolutionary “seek & destroy” nanomedicine that is linked to the iron-carrying protein named “lactoferrin” (the receptors of which are found significantly in most types of cancers). The results reveal to be highly promising with the help of gene therapy in cases of prostate cancer.

Matthew Lam, Worldwide Cancer Research team Science Communications Managers, states, “We are extremely delighted to observe the results of the given research. This research lays grounds for making significant advancements such that one-day gene therapy can be utilized for treating the patients with prostate cancer in the clinic. The intelligent chemistry that has been employed in the given study enables the delivery of a therapeutic system that can help in treating cancers of different types.”

HOPE RISES With Us!